Oncogenic mutations of EGFR gene are frequent in non-small cell lung cancer, and KIT or PDGFRA activating alterations are a hallmark of gastrointestinal stromal tumors. This evidence concerns the gene PDGFRA and gastrointestinal stromal tumor.